Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Restructuring Costs (2024 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Restructuring Costs for 2 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Restructuring Costs fell 2.29% year-over-year to $2.5 million, compared with a TTM value of $9.6 million through Sep 2025, changed N/A, and an annual FY2024 reading of $9.0 million, down 0.99% over the prior year.
  • Restructuring Costs was $2.5 million for Q3 2025 at Bicycle Therapeutics, up from $2.3 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $2.6 million in Q4 2024 and bottomed at $1.9 million in Q2 2024.